Skip to main content
Go to homepage

Efficacy and Safety of SAGE-547 Injection in the Treatment of Super-Refractory Status Epilepticus

Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status

Description:

For complete study information, please visit clinicaltrials.gov.

Interested in participating?
We are currently recruiting
IRB Study ID:
151016
Lead Investigator
James Besunder, DO

Director, Pediatric Critical Care; Pediatric Intensivist
Pediatric Critical Care Medicine (PICU)